Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial. - Grohar PJ; Heise R; Wedekind MF; Ballman K; Mascarenhas L; DuBois SG; Maki RG; Boguslawski EA; Gedminas JM; Wilson ER; Thomas E; Segers B; et al. (Nature medicine, 2026)